Guardant Health partners with Pfizer to support oncology drug development using smart liquid biopsy tech and expand testing access in China.

The upcoming report from Pfizer (PFE) is expected to reveal quarterly earnings of $0.64 per share, indicating a decline of 22% compared to the year-ago period. Analysts forecast revenues of $13.88 ...

Today, the American Kidney Fund (AKF) announces its 2025 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program. Corporate Members provide vital support to ...

Guardant Health (GH) announced a strategic collaboration with Pfizer (PFE) to support the development and commercialization of Pfizer’s ...

The Synbiotic Product Market, valued at approximately USD 0.87 billion in 2022, is poised for substantial growth, projected to surge at a healthy rate of over 8.3% during the forecast period spanning ...

We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this ...

It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump ...